NRC - National Research Corp Stock Price, Fair Value and News

34.27USD+0.03 (+0.09%)Market Closed

Market Summary

USD34.27+0.03

Market Closed

0.09%

NRC Stock Price

View Fullscreen

NRC RSI Chart

NRC Valuation

Market Cap

816.8M

Price/Earnings (Trailing)

26.37

Price/Sales (Trailing)

5.5

EV/EBITDA

19.84

Price/Free Cashflow

36.57

NRC Price/Sales (Trailing)

NRC Profitability

EBT Margin

26.90%

Return on Equity

63.26%

Return on Assets

25.3%

Free Cashflow Yield

2.73%

NRC Fundamentals

NRC Revenue

Revenue (TTM)

148.6M

Rev. Growth (Yr)

-0.37%

Rev. Growth (Qtr)

0.15%

NRC Earnings

Earnings (TTM)

31.0M

Earnings Growth (Yr)

33.38%

Earnings Growth (Qtr)

12.47%

Breaking Down NRC Revenue

Last 7 days

-0.4%

Last 30 days

-14.4%

Last 90 days

-14.5%

Trailing 12 Months

-23.1%

How does NRC drawdown profile look like?

NRC Financial Health

Current Ratio

0.67

Debt/Equity

0.12

Debt/Cashflow

6.64

NRC Investor Care

Dividend Yield

4.32%

Dividend/Share (TTM)

1.48

Buy Backs (1Y)

3.14%

Diluted EPS (TTM)

1.25

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	149.6M	148.5M	148.7M	148.6M
2022	150.9M	151.8M	151.7M	151.6M
2021	134.9M	140.1M	144.4M	148.0M
2020	130.4M	130.1M	131.1M	133.3M
2019	120.1M	123.5M	126.0M	128.0M
2018	118.3M	117.9M	118.9M	119.7M
2017	111.8M	114.1M	116.0M	117.6M
2016	103.9M	105.6M	107.4M	109.4M
2015	99.1M	99.5M	101.1M	102.3M
2014	93.7M	95.4M	96.6M	98.8M
2013	88.9M	90.6M	91.7M	92.6M
2012	78.4M	80.7M	83.5M	86.4M
2011	65.8M	70.0M	72.5M	75.8M
2010	0	59.6M	61.5M	63.4M
2009	0	0	0	57.7M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of National Research Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 27, 2024	nunnelly john n	sold (taxes)	-138,434	39.7	-3,487	-
Mar 27, 2024	nunnelly john n	acquired	138,422	14.95	9,259	-
Mar 01, 2024	common property trust	sold	-24,269,400	40.54	-598,653	-
Jan 05, 2024	amandla mk trust	sold	-105,092	40.2037	-2,614	-
Jan 04, 2024	amandla mk trust	sold	-189,617	41.2211	-4,600	-
Jan 03, 2024	amandla mk trust	sold	-5,018,760	41.7746	-120,139	-
Jan 03, 2024	common property trust	sold	-15,142,900	41.53	-364,625	-
Jan 02, 2024	hays michael d.	acquired	54,595	18.8	2,904	ceo & president
Jan 02, 2024	hays michael d.	sold (taxes)	-75,520	39.56	-1,909	ceo & president
Jan 02, 2024	amandla mk trust	sold	-8,106,250	40.3095	-201,100	-

Which funds bought or sold NRC recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 23, 2024	Venturi Wealth Management, LLC	added	44.83	516	1,664	-%
Apr 23, 2024	Gradient Investments LLC	sold off	-100	-514	-	-%
Apr 23, 2024	WETZEL INVESTMENT ADVISORS, INC.	unchanged	-	-1,717	8,283	-%
Apr 23, 2024	FIFTH THIRD BANCORP	reduced	-0.63	-64.00	12,556	-%
Apr 23, 2024	AMALGAMATED BANK	reduced	-76.31	-62,000	19,000	-%
Apr 22, 2024	MetLife Investment Management, LLC	unchanged	-	-34,819	286,375	-%
Apr 22, 2024	QV Investors Inc.	reduced	-13.38	-2,073,000	13,557,000	1.18%
Apr 19, 2024	AZZAD ASSET MANAGEMENT INC /ADV	added	35.91	263,499	993,799	0.12%
Apr 19, 2024	NORDEN GROUP LLC	new	-	5,170,190	5,170,190	0.06%
Apr 18, 2024	WOLFF WIESE MAGANA LLC	added	41.07	914	3,130	-%

Are Funds Buying or Selling NRC?

Are funds buying NRC calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own NRC

No. of Funds

Unveiling National Research Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Mar 08, 2024	kayne anderson rudnick investment management llc	13.38%	3,191,401	SC 13G/A
Mar 05, 2024	common property trust	16.2%	3,854,284	SC 13D/A
Feb 13, 2024	kayne anderson rudnick investment management llc	11.73%	2,881,525	SC 13G/A
Jan 04, 2024	amandla mk trust	19.4%	4,762,531	SC 13D/A
Feb 14, 2023	kayne anderson rudnick investment management llc	13.06%	3,224,166	SC 13G/A
Nov 01, 2022	amandla mk trust	21.6%	5,344,492	SC 13D/A
Jun 13, 2022	amandla mk trust	22.6%	5,685,594	SC 13D/A
Feb 11, 2022	kayne anderson rudnick investment management llc	13.03%	3,316,072	SC 13G/A
Dec 08, 2021	amandla mk trust	23.7%	6,028,722	SC 13D/A
Mar 22, 2021	common property trust	18.8%	4,772,522	SC 13D

Recent SEC filings of National Research Corp

View All Filings

Date Filed	Form Type	Document
Apr 11, 2024	DEF 14A	DEF 14A
Apr 03, 2024	3	Insider Trading
Mar 29, 2024	4	Insider Trading
Mar 08, 2024	SC 13G/A	Major Ownership Report
Mar 05, 2024	SC 13D/A	13D - Major Acquisition
Mar 05, 2024	4	Insider Trading
Feb 27, 2024	10-K	Annual Report
Feb 13, 2024	SC 13G/A	Major Ownership Report
Feb 13, 2024	8-K	Current Report
Jan 22, 2024	3	Insider Trading

Peers (Alternatives to National Research Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	448.5B	371.6B	-0.74%	-0.51%	20.04	1.21	14.64%	11.24%
CI	103.1B	195.3B	0.26%	37.72%	19.19	0.53	8.17%	-20.79%
CVS	86.2B	357.8B	-12.72%	-6.73%	10.32	0.24	10.95%	93.52%
HCA	84.5B	65.0B	-3.19%	11.59%	16.12	1.3	7.86%	-7.11%
CNC	40.6B	154.0B	-1.43%	12.08%	15.01	0.26	6.54%	124.79%
DVA	11.7B	12.1B	-0.12%	51.97%	16.99	0.97	4.57%	23.40%
UHS	11.4B	14.3B	-8.62%	17.22%	15.93	0.8	6.59%	6.24%
MID-CAP
CHE	9.3B	2.3B	-4.84%	8.83%	34.2	4.12	6.06%	9.17%
ACHC	6.5B	2.9B	-7.52%	-4.24%	-301.31	2.23	12.20%	-107.93%
AMN	2.2B	3.8B	-10.62%	-35.16%	10.28	0.57	-27.73%	-52.50%
AMEH	2.1B	1.4B	-5.65%	-0.29%	34.21	1.5	21.19%	34.42%
SMALL-CAP
ADUS	1.5B	1.1B	-8.44%	-16.43%	24.6	1.45	11.31%	35.83%
BKD	1.3B	3.0B	7.61%	59.68%	-6.94	0.44	6.74%	20.73%
BEAT	53.7M	-	-3.27%	-3.72%	-3.67	-	-	-12.94%
AMS	19.0M	21.3M	13.26%	5.28%	35.63	0.89	8.00%	-62.25%

National Research Corp News

Latest updates

National Research Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	0.1%	38.00	38.00	36.00	36.00	38.00	38.00	37.00	38.00	38.00	38.00	36.00	35.00	35.00	33.00	31.00	34.00	33.00	32.00	31.00	31.00	31.00
Costs and Expenses	-6.1%	26.00	28.00	27.00	27.00	26.00	27.00	26.00	27.00	25.00	25.00	24.00	23.00	25.00	22.00	22.00	23.00	21.00	22.00	21.00	21.00	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	21.00	21.00	21.00
S&GA Expenses	-6.2%	11.00	12.00	12.00	12.00	11.00	11.00	11.00	11.00	10.00	10.00	10.00	10.00	9.00	8.00	9.00	9.00	8.00	9.00	8.00	8.00	8.00
EBITDA Margin	-8.4%	0.27*	0.30*	0.31*	0.32*	0.33*	0.35*	0.36*	0.37*	0.38*	0.37*	0.38*	0.37*	-	-	-	-	-	-	-	-	-
Interest Expenses	67.8%	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.00	1.00	1.00	1.00
Income Taxes	20.7%	3.00	2.00	2.00	2.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	2.00	2.00	2.00	1.00	-0.38	3.00	2.00	2.00	2.00	2.00
Earnings Before Taxes	14.2%	11.00	10.00	9.00	9.00	9.00	11.00	11.00	11.00	12.00	13.00	12.00	12.00	10.00	12.00	9.00	11.00	11.00	10.00	9.00	10.00	10.00
EBT Margin	5.4%	0.27*	0.26*	0.26*	0.27*	0.28*	0.30*	0.31*	0.32*	0.33*	0.32*	0.32*	0.31*	-	-	-	-	-	-	-	-	-
Net Income	12.5%	9.00	8.00	7.00	7.00	7.00	8.00	8.00	9.00	10.00	10.00	9.00	9.00	8.00	10.00	8.00	12.00	9.00	8.00	7.00	8.00	8.00
Net Income Margin	7.8%	0.21*	0.19*	0.20*	0.20*	0.21*	0.23*	0.24*	0.24*	0.25*	0.25*	0.26*	0.26*	-	-	-	-	-	-	-	-	-
Free Cashflow	48.5%	8.00	5.00	4.00	5.00	6.00	6.00	8.00	6.00	10.00	8.00	10.00	13.00	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	1.9%	122	120	134	134	130	135	136	153	158	156	152	147	133	127	117	116	111	108	104	105	108
Current Assets	-1.5%	24.00	25.00	41.00	45.00	44.00	49.00	52.00	69.00	74.00	73.00	68.00	62.00	54.00	47.00	37.00	35.00	29.00	27.00	23.00	23.00	28.00
Cash Equivalents	73.8%	7.00	4.00	22.00	24.00	25.00	28.00	33.00	47.00	54.00	52.00	49.00	43.00	35.00	22.00	12.00	10.00	14.00	8.00	4.00	3.00	13.00
Net PPE	10.2%	28.00	26.00	23.00	19.00	17.00	16.00	14.00	13.00	12.00	11.00	12.00	12.00	12.00	12.00	12.00	13.00	14.00	14.00	14.00	14.00	14.00
Goodwill	0%	62.00	62.00	62.00	62.00	62.00	62.00	62.00	62.00	62.00	62.00	62.00	62.00	4.00	58.00	58.00	58.00	58.00	58.00	58.00	58.00	58.00
Liabilities	18.0%	73.00	62.00	56.00	60.00	58.00	67.00	68.00	72.00	72.00	73.00	75.00	74.00	69.00	71.00	71.00	79.00	78.00	79.00	78.00	82.00	89.00
Current Liabilities	-11.3%	36.00	41.00	34.00	36.00	33.00	41.00	40.00	42.00	40.00	39.00	40.00	37.00	32.00	32.00	32.00	40.00	38.00	38.00	37.00	39.00	47.00
Shareholder's Equity	-15.4%	49.00	58.00	78.00	75.00	72.00	68.00	69.00	81.00	85.00	83.00	76.00	73.00	64.00	57.00	46.00	37.00	33.00	29.00	26.00	23.00	19.00
Retained Earnings	16.3%	-30.53	-36.48	-16.85	-21.17	-25.18	-28.87	-31.24	-33.62	-36.11	-42.70	-49.30	-52.14	-61.37	-69.59	-79.17	-86.88	-93.36	-96.82	-100	-102	-106
Additional Paid-In Capital	0.8%	178	177	177	176	175	175	175	174	174	173	173	173	172	170	168	166	162	161	159	158	157
Shares Outstanding	-1.4%	24.00	25.00	25.00	25.00	25.00	25.00	25.00	25.00	25.00	25.00	25.00	25.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	531	-	-	-	444	-	-	-	533	-	-	-	654	-	-	-	566	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	19.3%	11,708	9,817	8,835	7,753	8,104	10,050	9,821	8,290	12,074	8,704	11,158	14,408	16,217	10,516	8,380	5,523	11,943	12,868	8,806	7,300	13,912
Share Based Compensation	279.4%	258	68.00	305	304	290	291	334	285	348	126	203	-54.00	-67.00	274	141	332	307	308	307	302	259
Cashflow From Investing	15.7%	-3,770	-4,470	-4,339	-3,199	-1,966	-3,983	-1,344	-2,542	-1,717	-992	-1,567	-4,238	-1,549	-748	-837	-590	-1,227	-1,149	-1,146	-1,134	-1,113
Cashflow From Financing	78.7%	-5,112	-24,015	-5,724	-5,856	-9,546	-10,473	-22,706	-12,858	-8,482	-4,060	-4,191	-1,429	-1,921	-20.00	-6,026	-7,536	-5,771	-7,257	-6,498	-16,820	-6,304
Dividend Payments	-89.3%	2,947	27,512	2,951	2,956	5,926	5,944	6,047	3,044	3,054	3,052	-	-	-	-	5,278	5,239	4,735	4,727	4,725	17,112	4,209
Buy Backs	4754.0%	14,999	309	1,819	1,972	2,317	3,145	15,475	6,679	-	-	-	-	-	-	-	-	-	-	-	-	-

NRC Income Statement

2023-12-31

Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenue	$ 148,580	$ 151,568	$ 147,954
Operating expenses:
Direct	56,015	57,049	52,350
Selling, general and administrative	46,621	42,699	38,960
Depreciation, amortization and impairment	5,899	5,277	6,374
Total operating expenses	108,535	105,025	97,684
Operating income	40,045	46,543	50,270
Other income (expense):
Interest income	820	168	14
Interest expense	(862)	(1,209)	(1,667)
Reclassification of cumulative foreign currency translation adjustment into earnings	0	(2,569)	0
Other, net	(41)	(118)	4
Total other income (expense)	(83)	(3,728)	(1,649)
Income before income taxes	39,962	42,815	48,621
Provision for income taxes	8,991	11,015	11,155
Net income	$ 30,971	$ 31,800	$ 37,466
Earnings per share of common stock:
Basic earnings per share (in dollars per share)	$ 1.26	$ 1.28	$ 1.47
Diluted earnings per share (in dollars per share)	$ 1.25	$ 1.27	$ 1.46
Weighted average shares and share equivalents outstanding
Basic (in shares)	24,540	24,922	25,422
Diluted (in shares)	24,673	25,052	25,640

NRC Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 6,653	$ 25,026
Trade accounts receivable	12,378	14,461
Prepaid expenses	4,228	2,386
Income taxes receivable	161	733
Other current assets	940	1,110
Total current assets	24,360	43,716
Net property and equipment	28,205	17,248
Intangible assets, net	1,471	1,611
Goodwill	61,614	61,614
Operating lease right-of-use assets	2,060	556
Deferred contract costs, net	1,453	2,441
Deferred income taxes	0	14
Other Assets, Noncurrent	3,274	3,261
Total assets	122,437	130,461
Current liabilities:
Current portion of notes payable, net of unamortized debt issuance costs	7,214	4,491
Accounts payable	1,301	1,153
Accrued wages and bonuses	3,953	4,551
Accrued expenses	4,893	3,983
Dividends payable	2,906	2,956
Deferred revenue	14,834	15,198
Income Taxes Payable	222	0
Other current liabilities	880	1,085
Total current liabilities	36,203	33,417
Notes payable, net of current portion and unamortized debt issuance costs	29,470	17,690
Deferred income taxes	4,139	5,274
Other long-term liabilities	3,670	2,047
Total liabilities	73,482	58,428
Shareholders’ equity:
Preferred stock, $0.01 par value, authorized 2,000,000 shares, none issued	0	0
Common stock, $0.001 par value; authorized 110,000,000 shares, issued 31,002,919 in 2023 and 30,922,181 in 2022, outstanding 24,219,887 in 2023 and 24,628,173 in 2022	31	31
Additional paid-in capital	178,213	175,453
Retained earnings (accumulated deficit)	(30,530)	(25,184)
Accumulated other comprehensive loss, foreign currency translation adjustment	0	0
Treasury stock, at cost; 6,783,032 Common shares in 2023 and 6,294,008 Common shares in 2022	(98,759)	(78,267)
Total shareholders’ equity	48,955	72,033
Total liabilities and shareholders’ equity	$ 122,437	$ 130,461

About National Research Corp

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, workforce engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

CEO	Mr. Michael D. Hays
WEBSITE	nrchealth.com
INDUSTRY	Healthcare Plans
EMPLOYEES	491

National Research Corp Frequently Asked Questions

What is the ticker symbol for National Research Corp? What does NRC stand for in stocks?

NRC is the stock ticker symbol of National Research Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of National Research Corp (NRC)?

As of Tue Apr 23 2024, market cap of National Research Corp is 816.78 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NRC stock?

You can check NRC's fair value in chart for subscribers.

What is the fair value of NRC stock?

You can check NRC's fair value in chart for subscribers. The fair value of National Research Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of National Research Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NRC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is National Research Corp a good stock to buy?

The fair value guage provides a quick view whether NRC is over valued or under valued. Whether National Research Corp is cheap or expensive depends on the assumptions which impact National Research Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NRC.

What is National Research Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, NRC's PE ratio (Price to Earnings) is 26.37 and Price to Sales (PS) ratio is 5.5. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NRC PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on National Research Corp's stock?

In the past 10 years, National Research Corp has provided 0.096 (multiply by 100 for percentage) rate of return.